A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/1999
11/02/1999	US5976597 Basic protein composition, basic peptide composition and application thereof
10/1999
10/30/1999	CA2269221A1 Active hedgehog protein conjugate, process for its production and use
10/28/1999	WO1999054456A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN αv-SUBUNIT EXPRESSION
10/28/1999	WO1999054351A1 Edg family gene, human h218
10/28/1999	WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999	WO1999053939A1 Treatment of osteoporosis with leptin
10/28/1999	WO1999053934A1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
10/28/1999	WO1999024460B1 Dipeptide nitriles
10/28/1999	WO1999004773A9 Method for inhibiting bone resorption
10/28/1999	CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999	CA2325821A1 Antisense oligonucleotides for the inhibition of integrin .alpha.v-subunit expression
10/27/1999	EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999	EP0952148A1 Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
10/27/1999	EP0951909A1 Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof
10/27/1999	EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999	EP0951546A2 Compositions and methods of use for osteoclast inhibitory factors
10/27/1999	EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999	EP0951467A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
10/27/1999	EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999	EP0951282A1 Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists
10/27/1999	CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999	CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999	CN1233243A Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
10/27/1999	CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/27/1999	CN1233176A Substituted tricyclics
10/27/1999	CN1233173A Therapeutic methods and compositions involving isoflavones
10/27/1999	CN1232687A Chinese medicine for treating bone wound
10/26/1999	US5973204 3-demethyl benzo(a)heptalene derivative used as antiinflammatory and muscle relaxant
10/26/1999	US5973188 Anticoagulant; prevention cell, protein binding
10/26/1999	US5973169 Ipriflavone preparation process
10/26/1999	US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999	US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999	US5972927 Antiinflammatory, antiallergic and bronchodilatory medicinal products, treatment of asthma
10/26/1999	US5972917 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders
10/26/1999	US5972913 Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
10/26/1999	US5972909 Removal wastes
10/26/1999	US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999	US5972899 Apoptosis induced by Shigella IpaB
10/26/1999	US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999	US5972652 Polynucleotides encoding secreted proteins
10/26/1999	CA2177576C Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
10/21/1999	WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999	WO1999052903A1 Prodrugs of benzofuranylmethyl carbamate nk1 antagonists
10/21/1999	WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999	WO1999052896A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/21/1999	WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999	WO1999052868A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999	WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999	WO1999052538A1 Composition containing a herbal medicinal substance and a pharmaceutical drug
10/21/1999	WO1999052524A1 Use of cannabinoids as anti-inflammatory agents
10/21/1999	WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999	WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999	WO1999030157A9 Neuropilins in methods for diagnosis and prognosis of cancer
10/21/1999	DE19848597A1 Stabilized compositions useful for stimulating collagen neogenesis in treatment of bone defects
10/21/1999	CA2328211A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors
10/21/1999	CA2327431A1 Pharmaceutical composition
10/21/1999	CA2326665A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
10/20/1999	EP0950709A1 Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
10/20/1999	EP0950661A1 Substituted tricyclics useful in sPLA2 induced diseases
10/20/1999	EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999	EP0950656A1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
10/20/1999	EP0950417A2 Treatment of skeletal disorders
10/20/1999	EP0950414A1 Use of a combination of an osteoinductive protein and a dorsalizing factor for cartilage induction
10/20/1999	EP0950110A1 Novel morphogen-responsive signal transducer and methods of use thereof
10/20/1999	EP0950065A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
10/20/1999	EP0950059A1 Cyclic sulfone derivatives
10/20/1999	EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999	EP0949931A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
10/20/1999	EP0949928A1 Androgenic and bisphosphonic agents coadministered to treat diseases
10/20/1999	EP0949927A2 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
10/20/1999	EP0949865A1 The use of cd4-binding small molecules to inhibit immune responses
10/20/1999	CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999	CN1232451A Substd. cyclic amine metalloprotease inhibitors
10/20/1999	CN1232448A Vitamin D analogues
10/20/1999	CN1232447A Hydroxamic acid derivs.
10/20/1999	CN1232399A Inhibitors of cysteine protease
10/20/1999	CN1232398A IL-8 receptor antagonists
10/20/1999	CN1231921A Traditional Chinese medicine plaster for treating osteoproliferation
10/20/1999	CN1045767C Pyrazole derivs, processes for preparation thereof and pharmaceutical composition comprising same
10/19/1999	US5969184 Amide compounds
10/19/1999	US5969095 Analogs of parathyroid hormone
10/19/1999	US5968969 Stable, long acting salts of carboxamides for the treatment of joint disease
10/19/1999	US5968917 Composition for prevention and treatment of osteoporosis comprising diosgenin, vitamin k, vitamin d
10/19/1999	US5968519 Antiinflammatory agents or analgesics in mammals
10/17/1999	CA2269262A1 Substituted tricyclics
10/17/1999	CA2269256A1 Substituted tricyclics
10/14/1999	WO1999051742A2 Dadd, death activator death domain protein
10/14/1999	WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999	WO1999051639A1 An integrin heterodimer and a subunit thereof
10/14/1999	WO1999051569A1 Calcilytic compounds
10/14/1999	WO1999051262A2 Use of igfi for treating articular cartilage disorders
10/14/1999	WO1999051241A1 Calcilytic compounds and method of use
10/14/1999	WO1999051217A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999	WO1999051096A1 Pulmonary and nasal delivery of raloxifene
10/14/1999	WO1999042075A3 Antibodies against human cd40
10/14/1999	WO1999039724A9 Treatment of bony defects with osteoblast precursor cells
10/14/1999	WO1999037604A3 Dialkyl ureas as calcitonin mimetics
10/14/1999	CA2327670A1 Pulmonary and nasal delivery of raloxifene
10/14/1999	CA2327279A1 Calcilytic compounds
10/14/1999	CA2327188A1 Calcilytic compounds and method of use

1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 820